General Information
Version
6.6
Revision date
2025-05-26
Product name
Monoclonal Anti-Cd8a azide free, antibody produced in rat
1.2.1 Relevant identified uses
Laboratory chemicals, Synthesis of substances
1.2.2. Uses advised against
The product is being supplied under the TSCA R&D Exemption
Emergency telephone
800-424-9300, +1-703- 527-3887
Icons in SDS
Company Information
company name
Sigma-Aldrich Inc
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
74.8% (dermal), 83.6% (inhalation)
Signal word
Danger
Hazard statements
May cause an allergic skin reaction. May cause genetic defects. May cause cancer. May cause damage to organs through prolonged or repeated exposure. May form combustible dust concentrations in air.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection. Do not breathe dust or mist. Contaminated work clothing must not be allowed out of the workplace.
Response
IF exposed or concerned Get medical advice or attention. IF ON SKIN Wash with plenty of water. If skin irritation or rash occurs: Get medical advice or attention. Take off contaminated clothing and wash it before reuse.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Keep container tightly closed. Keep away from heat, sparks, open flames and hot surfaces. - No smoking. Sanding and grinding dusts may be harmful if inhaled. This product contains crystalline silica which can cause lung cancer or silicosis. The risk of cancer depends on the duration and level of exposure to dust from sanding surfaces or mist from spray applications. Prevent dust accumulation. Emits toxic fumes when heated.
2.3 Other hazards
Fine dust clouds may form explosive mixtures with air. Handling and/or processing of this material may generate a dust which can cause mechanical irritation of the eyes, skin, nose and throat.
2.1 Classification of the substance or mixture
SKIN SENSITIZATION - Category 1 GERM CELL MUTAGENICITY - Category 1 CARCINOGENICITY - Category 1A SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 74.8% (dermal), 83.6% (inhalation)
